Jacobs Levy Equity Management, Inc Cidara Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$21.8 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.18 - $2.18 $701,751 - $1.3 Million	-594,705 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.48 - $2.35 $227,394 - $361,065	153,645 Added 34.84%	594,705 $1.33 Million
Q2 2021 Aug 16, 2021	SELL	$1.87 - $2.7 $437,948 - $632,331	-234,197 Reduced 34.68%	441,060 $891,000
Q1 2021 May 17, 2021	BUY	$2.06 - $3.01 $782,070 - $1.14 Million	379,646 Added 128.43%	675,257 $1.8 Million
Q4 2020 Feb 16, 2021	BUY	$1.99 - $3.25 $588,265 - $960,735	295,611 New	295,611 $591,000

Q2 2020 Aug 17, 2020	SELL	$2.39 - $4.0 $209,196 - $350,120	-87,530 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.74 - $4.26 $99,317 - $243,156	-57,079 Reduced 39.47%	87,530 $217,000
Q4 2019 Feb 14, 2020	BUY	$1.77 - $3.84 $255,957 - $555,298	144,609 New	144,609 $555,000
Q2 2019 Aug 13, 2019	SELL	$1.49 - $2.94 $143,014 - $282,190	-95,983 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$2.35 - $3.27 $60,380 - $84,019	-25,694 Reduced 21.12%	95,983 $254,000
Q4 2018 Feb 14, 2019	BUY	$2.1 - $4.5 $6,090 - $13,050	2,900 Added 2.44%	121,677 $286,000
Q3 2018 Nov 14, 2018	BUY	$3.7 - $5.25 $126,170 - $179,025	34,100 Added 40.27%	118,777 $523,000
Q2 2018 Aug 14, 2018	SELL	$3.75 - $6.05 $72,671 - $117,242	-19,379 Reduced 18.62%	84,677 $440,000
Q1 2018 May 15, 2018	BUY	$4.0 - $8.15 $120,556 - $245,632	30,139 Added 40.77%	104,056 $416,000
Q4 2017 Feb 13, 2018	BUY	$6.35 - $8.75 $151,517 - $208,783	23,861 Added 47.67%	73,917 $503,000
Q3 2017 Nov 14, 2017	SELL	$5.75 - $8.1 $81,144 - $114,307	-14,112 Reduced 21.99%	50,056 $405,000
Q2 2017 Nov 09, 2017	BUY	N/A	64,168	64,168 $481,000

Others Institutions Holding CDTX

# of Institutions

Shares Held

22.1M

Call Options Held

2.7K

Put Options Held

100

Bvf Inc San Francisco, CA

6.86M
Shares

$87.1 Million
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

3.35M
Shares

$42.5 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.55M
Shares

$32.4 Million
0.0% of portfolio
Alethea Capital Management, LLC San Diego, CA

1.6M
Shares

$20.3 Million
1.21% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

1.25M
Shares

$15.9 Million
0.0% of portfolio

View Full List

About Cidara Therapeutics, Inc.

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $889M
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

More about CDTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account